Biotech Financing Options and Their Implications
Oct 06, 2022•40 min
Episode description
In this session recorded at CMO Summit 2022, the panel discusses: What CMOs need to know about series funding, crossover and IPOHow to think about when to engage in these financing options based on the company stage, milestones, and budgetHow CMOs can best support the decision-making and fundraising processes Speakers: Nerissa Kreher, MD, MBA, CMO, Entrada TherapeuticsGeoff Meyerson, MBA, Co-Founder & CEO, Locust WalkTariq Kassum, MD, CEO, Celsius TherapeuticsAnn Barbier, MD, PhD, CMO, CAMP4 Therapeutics
For the best experience, listen in Metacast app for iOS or Android
